Allaband, Celeste http://orcid.org/0000-0003-1832-4858
Lingaraju, Amulya
Flores Ramos, Stephany http://orcid.org/0000-0002-1918-9769
Kumar, Tanya
Javaheri, Haniyeh
Tiu, Maria D.
Dantas Machado, Ana Carolina
Richter, R. Alexander
Elijah, Emmanuel
Haddad, Gabriel G.
Leone, Vanessa A.
Dorrestein, Pieter C. http://orcid.org/0000-0002-3003-1030
Knight, Rob http://orcid.org/0000-0002-0975-9019
Zarrinpar, Amir http://orcid.org/0000-0001-6423-5982
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HL157445, AI163483, HL148801, CA265719, DK120515, DK063491, CA014195, AA011999, TR001442, OD017863, DK120515, DK063491, CA014195, AA011999, TR001442, DK120515, DK063491, CA014195, AA011999, TR001442, GM719876, DK120515, DK063491, CA014195, AA011999, TR001442, DK120515, DK063491, CA014195, AA011999, TR001442, HL148801-02S1, DK120515, DK063491, CA014195, AA011999, TR001442, HL157445, DK120515, DK063491, CA014195, AA011999, TR001442, DK120515, DK063491, CA014195, AA011999, TR001442)
U.S. Department of Veterans Affairs (I01 BX005707)
American Heart Association
Paul and Daisy Soros Fellowships for New Americans
Article History
Received: 27 October 2022
Accepted: 8 May 2024
First Online: 1 July 2024
Competing interests
: A.Z. is a co-founder and a chief medical officer, and holds equity in Endure Biotherapeutics. P.C.D. is an advisor to Cybele and co-founder and advisor to Ometa and Enveda with previous approval from the University of California, San Diego. All other authors declare no competing interests.